about
Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C.Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL).Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint WorkshopAssessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease.Malnutrition negatively impacts the quality of life of patients with cirrhosis: An observational study.The Burden of Rehospitalization for Patients With Liver Cirrhosis.The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study.Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens.Translation and validation of chronic liver disease questionnaire (CLDQ) in Tamil language.Quality of life in liver transplant recipients and the influence of sociodemographic factors.Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients.Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis.Modeling the benefits and harms of surveillance for hepatocellular carcinoma: Information to support informed choices.Psychological status of liver cirrhosis patients might impact disease self-management learning.Factors associated with Health-Related Quality of Life in Kidney Transplant Recipients in France.
P2860
Q30393824-243E275F-39D8-4545-8016-1CB695BB34EFQ36560817-8F561EC8-95EC-4A76-8C6D-F86F812139A3Q36987260-19ED16AF-09A8-4A33-BEDC-9F37D62F3F29Q37236384-2F58A7FE-C17F-473E-86B5-C73D132F7B68Q37651904-3D483B9E-A141-408B-82D9-0DD5C042D0CFQ38702025-268D76BD-F93A-4719-AE58-E533AA7822B1Q41682696-6708D351-B0A7-4053-80A1-CE602D8A279DQ42226250-8419C367-4655-4C00-BAF9-A25B44BD10D0Q47558563-10D28604-F2EA-4570-BC36-F7924EA57937Q47608326-D4E4C627-D4D3-4FA5-BD09-EBF4956DF006Q47785236-B43AA4C2-EFF8-4DE6-95A2-12D5548CF444Q47945856-182F1D46-304F-4372-8C98-265DB3278F4CQ48292446-E3032A68-37BC-4353-B72B-79E0DF043D90Q50697371-6EAB21CA-353F-42C4-A5CB-383CACF5A0E0Q54967120-F17D6E3A-869D-4122-835E-62DC0A1AA3D7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Quality of life in cirrhosis.
@en
type
label
Quality of life in cirrhosis.
@en
prefLabel
Quality of life in cirrhosis.
@en
P2093
P2860
P1476
Quality of life in cirrhosis.
@en
P2093
Anthony Loria
Carey Escheik
N Lynn Gerber
Zobair M Younossi
P2860
P2888
P356
10.1007/S11894-012-0301-5
P577
2013-01-01T00:00:00Z
P6179
1028951088